(Reuters) – AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” since the pandemic.
The company also said it would proceed to withdraw the vaccine Vaxzevria’s marketing authorizations within Europe.
“As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines,” the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.
The firm’s application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.
London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.
What is an AdBlocker? An AdBlocker is a software or function that is intended to…
To be successful at poker requires a combination of talent, luck, and, most importantly, knowledge. This…
Anyone who wants to become a poker professional must first come to terms with the famous…
Introduction Welcome to the thrilling world of Cobra Casino, your ultimate destination for online gaming…
Introduction to Bitkingz Casino Bitkingz Casino offers an exciting blend of traditional gaming and the…
In a world where technology is increasingly becoming a part of our everyday lives, ChatGPT…